Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris
Status:
Not yet recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
Single Center, Double Blind, Placebo- Controlled Study of 20 subjects with 10 active drug/10
placebo
Standardized baseline/pre-treatments and follow-up images will be taken.
Subjects will receive injection of either study drug or placebo to the Depressor Anguli Oris.
Follow ups will occur at 2 weeks, 4 weeks, and 12 weeks.